These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 8934538)

  • 1. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.
    Berx G; Cleton-Jansen AM; Strumane K; de Leeuw WJ; Nollet F; van Roy F; Cornelisse C
    Oncogene; 1996 Nov; 13(9):1919-25. PubMed ID: 8934538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
    Berx G; Cleton-Jansen AM; Nollet F; de Leeuw WJ; van de Vijver M; Cornelisse C; van Roy F
    EMBO J; 1995 Dec; 14(24):6107-15. PubMed ID: 8557030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
    De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
    J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer.
    Huiping C; Sigurgeirsdottir JR; Jonasson JG; Eiriksdottir G; Johannsdottir JT; Egilsson V; Ingvarsson S
    Br J Cancer; 1999 Dec; 81(7):1103-10. PubMed ID: 10584868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.
    Palacios J; Sarrió D; García-Macias MC; Bryant B; Sobel ME; Merino MJ
    Mod Pathol; 2003 Jul; 16(7):674-8. PubMed ID: 12861063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the human E-cadherin (CDH1) gene.
    Berx G; Becker KF; Höfler H; van Roy F
    Hum Mutat; 1998; 12(4):226-37. PubMed ID: 9744472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse growth pattern affects E-cadherin expression in invasive breast cancer.
    Brinck U; Jacobs S; Neuss M; Tory K; Rath W; Kulle B; Füzesi L
    Anticancer Res; 2004; 24(4):2237-42. PubMed ID: 15330167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?
    Cleton-Jansen AM
    Breast Cancer Res; 2002; 4(1):5-8. PubMed ID: 11879552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas.
    Rieger-Christ KM; Pezza JA; Dugan JM; Braasch JW; Hughes KS; Summerhayes IC
    Mol Pathol; 2001 Apr; 54(2):91-7. PubMed ID: 11322170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.
    de Groot JS; Ratze MA; van Amersfoort M; Eisemann T; Vlug EJ; Niklaas MT; Chin SF; Caldas C; van Diest PJ; Jonkers J; de Rooij J; Derksen PW
    J Pathol; 2018 Aug; 245(4):456-467. PubMed ID: 29774524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast.
    Mastracci TL; Tjan S; Bane AL; O'Malley FP; Andrulis IL
    Mod Pathol; 2005 Jun; 18(6):741-51. PubMed ID: 15696125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.
    Vos CB; Cleton-Jansen AM; Berx G; de Leeuw WJ; ter Haar NT; van Roy F; Cornelisse CJ; Peterse JL; van de Vijver MJ
    Br J Cancer; 1997; 76(9):1131-3. PubMed ID: 9365159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
    Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
    BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast.
    Droufakou S; Deshmane V; Roylance R; Hanby A; Tomlinson I; Hart IR
    Int J Cancer; 2001 May; 92(3):404-8. PubMed ID: 11291078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.
    Sarrió D; Moreno-Bueno G; Hardisson D; Sánchez-Estévez C; Guo M; Herman JG; Gamallo C; Esteller M; Palacios J
    Int J Cancer; 2003 Aug; 106(2):208-15. PubMed ID: 12800196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast.
    Kanai Y; Oda T; Tsuda H; Ochiai A; Hirohashi S
    Jpn J Cancer Res; 1994 Oct; 85(10):1035-9. PubMed ID: 7961105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of E-cadherin in breast cancer. patterns, mechanisms and clinical significance.
    Asgeirsson KS; Jónasson JG; Tryggvadóttir L; Olafsdóttir K; Sigurgeirsdóttir JR; Ingvarsson S; Ogmundsdóttir HM
    Eur J Cancer; 2000 Jun; 36(9):1098-106. PubMed ID: 10854942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation.
    Keller G; Vogelsang H; Becker I; Hutter J; Ott K; Candidus S; Grundei T; Becker KF; Mueller J; Siewert JR; Höfler H
    Am J Pathol; 1999 Aug; 155(2):337-42. PubMed ID: 10433926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four human breast cancer cell lines with biallelic inactivating alpha-catenin gene mutations.
    Hollestelle A; Elstrodt F; Timmermans M; Sieuwerts AM; Klijn JG; Foekens JA; den Bakker MA; Schutte M
    Breast Cancer Res Treat; 2010 Jul; 122(1):125-33. PubMed ID: 19763817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-Cadherin Mutational Landscape and Outcomes in Breast Invasive Lobular Carcinoma.
    Djerroudi L; Bendali A; Fuhrmann L; Benoist C; Pierron G; Masliah-Planchon J; Kieffer Y; Carton M; Tille JC; Cyrta J; Ramtohul T; Bonneau C; Caly M; Renault V; Bidard FC; Mechta-Grigoriou F; Vincent-Salomon A
    Mod Pathol; 2024 Oct; 37(10):100570. PubMed ID: 39025406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.